Uridine 5'-monophosphate-13C9 (dilithium)

Uridine 5'-monophosphate-13C9 (dilithium)

• UNSPSC Description: Uridine 5'-monophosphate-13C9 (5'- Uridylic acid-13C9) dilithium is 13C-labeled Uridine 5'-monophosphate (HY-101981). Uridine 5'-monophosphate (5'- Uridylic acid), a monophosphate form of UTP, can be acquired either from a de novo pathway or degradation products of nucleotides and nucleic acids in vivo and is a major nucleotide analogue in mammalian milk.
• Target Antigen: Endogenous Metabolite; Isotope-Labeled Compounds
• Type: Isotope-Labeled Compounds
• Related Pathways: Metabolic Enzyme/Protease;Others
• Applications: Metabolism-protein/nucleotide metabolism
• Field of Research: Others
• Assay Protocol: https://www.medchemexpress.com/uridine-5-monophosphate-13c9-dilithium.html
• Solubility: 10 mM in DMSO
• Smiles: O=P(O[Li])(O[Li])O[13CH2][13C@H]1O[13C@@H](N([13C](N2)=O)[13CH]=[13CH][13C]2=O)[13C@H](O)[13C@@H]1O
• Molecular Weight: 344.98
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.|[2]Li G, et al. Uridine/UMP metabolism and their function on the gut in segregated early weaned piglets. Food Funct. 2019 Jul 17;10(7):4081-4089.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported